ロード中...
Expression of Programmed Cell Death-Ligands in Hepatocellular Carcinoma: Correlation With Immune Microenvironment and Survival Outcomes
The quantity of programmed cell death-ligand 1 (PD-L1) is regarded as a predicting factor of clinical response to anti-PD-1 axis immunotherapy. However, the expression of PD-L1 and its prognostic value in hepatocellular carcinoma (HCC) patients remain debated. Meanwhile, the molecular features of PD...
保存先:
| 出版年: | Front Oncol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6749030/ https://ncbi.nlm.nih.gov/pubmed/31572677 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00883 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|